Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Newly Diagnosed ◽

Intensity Modulated ◽

Temozolomide Chemotherapy

Phase II Trial of Hypofractionated Intensity Modulated Radiotherapy to 60 Gy in 10 Fractions with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.268 ◽

2011 ◽

Vol 81 (2) ◽

pp. S130

Author(s):

K. Reddy ◽

D. Damek ◽

L. Gaspar ◽

D. Ney ◽

B. Kavanagh ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Trial ◽

Newly Diagnosed ◽

Intensity Modulated ◽

Temozolomide Chemotherapy

NCOG-18. PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE

Neuro-Oncology ◽

10.1093/neuonc/nox168.579 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi141-vi142

Author(s):

Ashlee Loughan ◽

Danielle Shafer ◽

Autumn Lanoye ◽

Sarah Braun ◽

Paul Dent ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Dimethyl Fumarate ◽

Newly Diagnosed ◽

A Phase I Dose per Fraction Escalation Study of Hypofractionated Intensity-modulated Radiation Therapy with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.251 ◽

2009 ◽

Vol 75 (3) ◽

pp. S103

Author(s):

C. Chen ◽

D. Damek ◽

A. Waziri ◽

L.E. Gaspar ◽

K. Lillehei ◽

...

Keyword(s):

Radiation Therapy ◽

Phase I ◽

Intensity Modulated Radiation Therapy ◽

Newly Diagnosed ◽

Intensity Modulated ◽

Temozolomide Chemotherapy ◽

Dose Per Fraction

Phase I trial of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly-diagnosed glioblastoma multiforme (GBM).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e13518 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e13518-e13518

Author(s):

Gordana Vlahovic ◽

Gerald E. Archer ◽

Elizabeth Reap ◽

Annick Desjardins ◽

Katherine B. Peters ◽

...

Keyword(s):

T Cell ◽

Glioblastoma Multiforme ◽

Phase I ◽

Regulatory T Cell ◽

Phase I Trial ◽

Newly Diagnosed ◽

Antitumor Immunotherapy ◽

Cell Inhibition

RTHP-21. CLINICAL OUTCOMES AND PATTERN OF FAILURE IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME TREATED WITH DOSE ESCALATION INTENSITY MODULATED RADIOTHERAPY (IMRT)

Neuro-Oncology ◽

10.1093/neuonc/now212.747 ◽

2016 ◽

Vol 18 (suppl_6) ◽

pp. vi178-vi178

Author(s):

Thirada Ruetairuengnont ◽

Chakkapong Chakkabat

Keyword(s):

Glioblastoma Multiforme ◽

Clinical Outcomes ◽

Dose Escalation ◽

Newly Diagnosed ◽

Pattern Of Failure ◽

Intensity Modulated ◽

Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy

Journal of Neuro-Oncology ◽

10.1007/s11060-012-0854-z ◽

2012 ◽

Vol 108 (3) ◽

pp. 521-525 ◽

Cited By ~ 7

Author(s):

Christopher M. McPherson ◽

Margie Gerena-Lewis ◽

John C. Breneman ◽

Ronald E. Warnick

Keyword(s):

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Study ◽

Newly Diagnosed ◽

Bcnu Wafers ◽

Temozolomide Chemotherapy ◽

Fractionated Radiation

Abstract C56: NCCTG phase I trial of everolimus (RAD001) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients

10.1158/1535-7163.targ-09-c56 ◽

2009 ◽

Author(s):

Jann N. Sarkaria ◽

Evanthia Galanis ◽

Patrick Peller ◽

Paul Brown ◽

Wenting Wu ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Newly Diagnosed ◽

Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials

Journal of Neuro-Oncology ◽

10.1007/s11060-015-1791-4 ◽

2015 ◽

Vol 123 (2) ◽

pp. 251-257 ◽

Cited By ~ 12

Author(s):

Julie A. Carlson ◽

Krishna Reddy ◽

Laurie E. Gaspar ◽

Douglas Ney ◽

Brian D. Kavanagh ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Newly Diagnosed ◽

Phase Ii Trials ◽

Intensity Modulated ◽

Prospective Phase

Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy for Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.03.061 ◽

2007 ◽

Vol 69 (3) ◽

pp. 825-830 ◽

Cited By ~ 22

Author(s):

Allen M. Chen ◽

Susan Chang ◽

Jean Pouliot ◽

Penny K. Sneed ◽

Michael D. Prados ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Gross Total Resection ◽

Newly Diagnosed ◽

Total Resection ◽

Hyperfractionated Radiotherapy ◽

Iodine 125

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.05.064 ◽

2011 ◽

Vol 81 (2) ◽

pp. 468-475 ◽

Cited By ~ 52

Author(s):

Jann N. Sarkaria ◽

Evanthia Galanis ◽

Wenting Wu ◽

Patrick J. Peller ◽

Caterina Giannini ◽

...

Keyword(s):

Radiation Therapy ◽

Treatment Group ◽

Glioblastoma Multiforme ◽

Phase I ◽

Cancer Treatment ◽

Phase I Trial ◽

Newly Diagnosed ◽

North Central ◽